Cargando…

Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease

Idiopathic Parkinson’s disease (PD) is a complex disease caused by multiple, mainly unknown, genetic and environmental factors. The Ventral root avulsion 1 (Vra1) locus on rat chromosome 8 includes the Glutathione S-transferase alpha 4 (Gsta4) gene and has been identified in crosses between Dark Ago...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jewett, Michael, Jimenez-Ferrer, Itzia, Swanberg, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532586/ https://www.ncbi.nlm.nih.gov/pubmed/28672859 http://dx.doi.org/10.3390/brainsci7070073

Ejemplares similares

Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson’s Disease
por: Jewett, Michael, et al.
Publicado: (2018)

Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
por: Ji Yuan, Wen, et al.
Publicado: (2008)

Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I, et al.
Publicado: (2015)

Regulation of Actg1 and Gsta2 is possible mechanism by which capsaicin alleviates apoptosis in cell model of 6-OHDA-induced Parkinson's disease
por: Liu, Jiahui, et al.
Publicado: (2020)

Erratum to: Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I., et al.
Publicado: (2015)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
por: Tu, Li, et al.
Publicado: (2019)

Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson’s Disease
por: Kurowska, Zuzanna, et al.
Publicado: (2016)

Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
por: Walker, Matthew D, et al.
Publicado: (2013)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

Effects of Treadmill Exercise on the Recovery of Dopaminergic Neuron Loss and Muscle Atrophy in the 6-OHDA Lesioned Parkinson's Disease Rat Model
por: Choe, Myoung-Ae, et al.
Publicado: (2012)

Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson's disease model
por: Shalavadi, M. H., et al.
Publicado: (2012)

Propolis as a Potential Disease-Modifying Strategy in Parkinson’s disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model
por: C. Gonçalves, Valeria, et al.
Publicado: (2020)

Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA–induced dopaminergic denervation
por: Gasparotto, Juciano, et al.
Publicado: (2017)

The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
por: Lu, Xi, et al.
Publicado: (2014)

Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020)

Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone
por: Rodrigues, Laís D., et al.
Publicado: (2019)

Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease
por: Barata-Antunes, Sandra, et al.
Publicado: (2020)

Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease
por: Voronin, Mikhail V., et al.
Publicado: (2019)

Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA
por: Kuter, Katarzyna, et al.
Publicado: (2017)

Identification of Bilateral Changes in TID1 Expression in the 6-OHDA Rat Model of Parkinson's Disease
por: Proft, Juliane, et al.
Publicado: (2011)

The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson’s Disease
por: Yu, Hao, et al.
Publicado: (2021)

Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson's model through apoptosis and iron accumulation inhibition
por: Li, Xin, et al.
Publicado: (2020)

Agathobaculum butyriciproducens Shows Neuroprotective Effects in a 6-OHDA-Induced Mouse Model of Parkinson’s Disease
por: Lee, Da Woon, et al.
Publicado: (2022)

Use of [(18)F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats
por: Kyono, Kiyoshi, et al.
Publicado: (2011)

Irisflorentin improves α-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson’s disease therapy
por: Chen, Yue-Mi, et al.
Publicado: (2015)

Neuroprotective Effect of 1,4-Naphthoquinones in an In Vitro Model of Paraquat and 6-OHDA-Induced Neurotoxicity
por: Menchinskaya, Ekaterina, et al.
Publicado: (2021)

Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson's Disease through the Inflammation Pathway
por: Wei, Renrong, et al.
Publicado: (2019)

P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD
por: Ma, Jiangnan, et al.
Publicado: (2020)

6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson's Disease
por: Murillo, Maria Del Pilar, et al.
Publicado: (2023)

Treadmill Running Combined with Microdialysis to Evaluate Motor Deficits and Improvement Following Dopaminergic Grafts in 6-OHDA Lesioned Rats
por: Hattori, S., et al.
Publicado: (1992)

Intranasal HSP70 administration protects against dopaminergic denervation and modulates neuroinflammatory response in the 6-OHDA rat model
por: Tiefensee Ribeiro, Camila, et al.
Publicado: (2021)

Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity
por: Huang, Chun, et al.
Publicado: (2018)

A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats
por: Choudhury, Mohammed Emamussalehin, et al.
Publicado: (2011)

SKP-SCs transplantation alleviates 6-OHDA-induced dopaminergic neuronal injury by modulating autophagy
por: Ma, Chengxiao, et al.
Publicado: (2021)

Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties
por: Ximenes, José Christian Machado, et al.
Publicado: (2015)

Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson’s Disease via the Nrf2/Keap1 Pathway
por: Chen, Qiu-Xu, et al.
Publicado: (2022)

Erratum to “Inhibition of Endoplasmic Reticulum Stress is Involved in the Neuroprotective Effect of bFGF in the 6-OHDA-Induced Parkinson’s Disease Model”
por: Cai, Pingtao, et al.
Publicado: (2023)

GSTA4 mediates reduction of cisplatin ototoxicity in female mice
por: Park, Hyo-Jin, et al.
Publicado: (2019)

Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease
por: Boronat-García, Alejandra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_igi86rq8jkd4alg6g8mb0drp0b